222 results on '"Creemers, G. J."'
Search Results
2. Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial
3. Perception of prognosis and health-related quality of life in patients with advanced cancer: results of a multicentre observational study (eQuiPe)
4. Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk (“ugly”) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)
5. The diagnostic accuracy of local staging in colon cancer based on computed tomography (CT): evaluating the role of extramural venous invasion and tumour deposits
6. Improved Outcomes for Responders After Treatment with Induction Chemotherapy and Chemo(re)irradiation for Locally Recurrent Rectal Cancer
7. ASO Visual Abstract: Treatment Strategies and Prognosis in Patients with Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study
8. Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands
9. Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial
10. Preliminary results of a cohort study of induction chemotherapy‐based treatment for locally recurrent rectal cancer
11. Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
12. Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands
13. Quality of Life Is Associated With Survival in Patients With Gastric Cancer: Results From the Randomized CRITICS Trial
14. Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe
15. Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study
16. The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
17. 1473P Gender differences in treatment allocation and survival in a real-world metastatic pancreatic cancer cohort
18. 1589P Systemic treatment strategies and outcomes of patients with peritoneal metastases of gastric origin
19. Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting
20. Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study
21. Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992–2008
22. Feasibility of reirradiation in the treatment of locally recurrent rectal cancer
23. Curative treatment of locally recurrent rectal cancer: is induction chemotherapy warranted?
24. Impact of a history of metastases or synchronous metastases on survival in patients with locally recurrent rectal cancer
25. A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer
26. No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy
27. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
28. Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy
29. 1526P First and second-line palliative systemic treatment outcomes in a real-world metastatic pancreatic cancer cohort
30. Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer
31. Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands
32. Trastuzumab and pertuzumab added to neoadjuvant chemoradiotherapy in resectable HER2+ esophageal adenocarcinoma patients: An update on survival and predictive biomarkers in the TRAP study
33. Bevacizumab as adjuvant treatment for colon cancer: Updated results from the AVANT phase III study by the GERCOR group
34. Second-line palliative systemic treatment for synchronous metastatic esophagogastric cancer: A population-based study
35. Increased assessment of HER2 in metastatic gastroesophageal cancer patients: A nationwide population-based cohort study
36. Updated survival analysis of the randomized phase III trial comparing S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer (SALTO) by the Dutch colorectal cancer group
37. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
38. Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study.
39. Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004
40. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity
41. Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer
42. Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial.
43. Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy
44. Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer
45. Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands
46. Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer
47. 1449P Hospital volume and beyond first-line palliative systemic treatment administration in metastatic esophagogastric adenocarcinoma: A population-based study
48. Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: Analysis of the AURELIA trial
49. 811P - Second-line palliative systemic treatment for synchronous metastatic esophagogastric cancer: A population-based study
50. 813P - Increased assessment of HER2 in metastatic gastroesophageal cancer patients: A nationwide population-based cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.